BONAIRESWISS A.G. is a company founded in March 2017. Our mission is to develop and produce drugs of very high dilution with zero toxicity and no side effects. As a new, newly founded company, we go through times of fluctuation in our sales of raw material and therefore in our investment capacity. Seeking to keepRead more about Our Crowdfunding[…]

Different cells, like leukocytes, fibroblasts, and vascular endothelial cells together form a tumor microenvironment. The leukocytes interact with tumor cells to influence the development of tumors. In general, monocytes/macrophages can be polarized to M1 or M2 macrophages, that is, macrophages can differentiate into a classically or alternatively activated phenotype. Classically activated macrophages, also known asRead more about CHANGING TUMOR-ASSOCIATED CELLS[…]

Metastatic melanoma is the most aggressive form of skin cancer, and the most rapidly expanding cancer in terms of worldwide incidence with a 5 years survival rate of less than 10% after metastasis establishment. Besides that, chemo and radiotherapeutic approaches in melanoma treatment have been shown disappointing results, also resulting in severe adverse effects. PreviousRead more about Metastatic Melanoma[…]